This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Q2 FY27 consolidated revenue rises 10%, profit after tax rises 26%
LAXMIDENTL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 0.9 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the consolidated quarter ended 30 September 2026, revenue from operations was INR 795.21 million versus INR 722.65 million a year earlier; profit after tax was INR 95.09 million versus INR 75.57 million. Operating profit before other income, interest, depreciation and tax was INR 152.65 million; margin rose to 19.2% from 15.3%. Standalone Q2 profit after tax fell, and its cash flow shows a related-party loan.
Profit growth and a 3.9 percentage-point margin gain support sentiment, but standalone profit fell and a related-party loan appears in cash flow.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹79.52 Cr | ₹72.27 Cr | +10.0% |
| Operating profit | ₹9.57 Cr | ₹7.04 Cr | +36.0% |
| Profit after tax | ₹10.04 Cr | ₹8.53 Cr | +17.6% |
| EBITDA margin | 19.2% | 15.3% | +3.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.